Obid R, Redlich M, Tomeh C. The treatment of laryngeal cancer. Oral Maxillofac Surg Clin North Am 2019; 31(1): 1-11. DOI:10.1016/j.coms.2018.09.001
Pries R, Wollenberg B. Cytokines in head and neck cancer. Cytokine Growth Factor Rev 2006; 17(3): 141-146. DOI:10.1016/j.cytogfr.2006.02.001
De Virgilio A, Ralli M, Longo L, Mancini P, Attanasio G, Atturo F, et al. Electrochemotherapy in head and neck cancer: A review of an emerging cancer treatment. Oncol Lett 2018; 16(3): 3415-3423. DOI:10.3892/ol.2018.9140
Marur S, Forastiere AA. Head and neck squamous cell carcinoma: Update on epidemiology, diagnosis, and treatment. Mayo Clin Proc 2016; 91(3): 386-396. DOI:10.1016/j.mayocp.2015.12.017
Steuer CE, El-Deiry M, Parks JR, Higgins KA, Saba NF. An update on larynx cancer. CA Cancer J Clin 2017; 67(1): 31-50. DOI:10.3322/caac.21386
Ciafre S, Carito V, Ferraguti G, Greco A, Chaldakov GN, Fiore M, et al. How alcohol drinking affects our genes: an epigenetic point of view. Biochem Cell Biol 2018. DOI:10.1139/bcb-2018-0248
Attilia F, Perciballi R, Rotondo C, Capriglione I, Iannuzzi S, Attilia ML, et al. Pharmacological treatment of alcohol use disorder. Scientific evidence. Riv Psichiatr. 2018; 53(3): 123-127. DOI:10.1708/2925.29414
Ceccanti M, Iannitelli A, Fiore M. Italian Guidelines for the treatment of alcohol dependence. Riv Psichiatr 2018; 53(3): 105-106. DOI:10.1708/2925.29410
Ceccanti M, Coriale G, Hamilton DA, Carito V, Coccurello R, Scalese B, et al. Virtual Morris task responses in individuals in an abstinence phase from alcohol. Can J Physiol Pharmacol. 2018; 96(2): 128-136. DOI:10.1139/ cjpp-2017-0013
Ferraguti G, Ciolli P, Carito V, Battagliese G, Mancinelli R, Ciafre S, et al. Ethylglucuronide in the urine as a marker of alcohol consumption during pregnancy: Comparison with four alcohol screening questionnaires. Toxicol Lett 2017; 275: 49-56. DOI:10.1016/j.toxlet.2017.04.016
Ceccanti M, Hamilton D, Coriale G, Carito V, Aloe L, Chaldakov G, et al. Spatial learning in men undergoing alcohol detoxification. Physiol Behav 2015; 149: 324-330. DOI:10.1016/j.physbeh.2015.06.034
Ferster APO, Schubart J, Kim Y, Goldenberg D. Association between laryngeal cancer and asbestos exposure: A systematic review. JAMA Otolaryngol Head Neck Surg 2017; 143(4): 409-416. DOI:10.1001/ jamaoto.2016.3421
Bychkov VA, Nikitina EG, Ibragimova MK, Kaigorodova EV, Choinzonov EL, Litviakov NV. Comprehensive meta-analytical summary on human papillomavirus association with head and neck cancer. Exp Oncol. 2016; 38(2): 68-72.
Syrjanen S, Rautava J, Syrjanen K. HPV in head and neck cancer - 30 years of history. Recent Results Cancer Res 2017; 206: 3-25. DOI:10.1007/978-3-319-43580-0_1
Shaikh MH, McMillan NA, Johnson NW. HPV-associated head and neck cancers in the Asia Pacific: A critical literature review and meta-analysis. Cancer Epidemiol. 2015; 39(6): 923-938. DOI:10.1016/j.canep.2015.09.013
Bologna-Molina RE, Castaneda-Castaneira RE, Molina- Frechero N, Perez-Rodriguez E. Human papilloma virus and its association with oral cancer. Rev Med Inst Mex Seguro Soc 2006; 44(2): 147-153.
Li X, Gao L, Li H, Gao J, Yang Y, Zhou F, et al. Human papillomavirus infection and laryngeal cancer risk: a systematic review and meta-analysis. J Infect Dis. 2013; 207(3): 479-488. DOI:10.1093/infdis/jis698
Tribius S, Wurdemann N, Laban S, Sharma SJ, Wagner S, Hoffmann TK, et al. Update on HPV-associated head and neck cancer-highlights of the 2018 ASCO Annual Meeting. HNO. 2018; 66(12): 888-895. DOI:10.1007/ s00106-018-0577-3
Wittekindt C, Wuerdemann N, Gattenlohner S, Brobeil A, Wierzbicka M, Wagner S, et al. The role of high-risk human papillomavirus infections in laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2017; 274(11): 3837-3842. DOI:10.1007/s00405-017-4718-1
Mallen-St Clair J, Alani M, Wang MB, Srivatsan ES. Human papillomavirus in oropharyngeal cancer: The changing face of a disease. Biochim Biophys Acta. 2016; 1866(2): 141-150. DOI:10.1016/j.bbcan.2016.07.005
Arndt O, Johannes A, Zeise K, Brock J. [High-risk HPV types in oral and laryngeal papilloma and leukoplakia]. Laryngorhinootologie. 1997; 76(3): 142-149. 10.1055/s- 2007-997403
de Vincentiis M, De Virgilio A, Bussu F, Gallus R, Gallo A, Bastanza G, et al. Oncologic results of the surgical salvage of recurrent laryngeal squamous cell carcinoma in a multicentric retrospective series: emerging role of supracricoid partial laryngectomy. Head Neck. 2015; 37(1): 84-91. DOI:10.1002/hed.23563
Bussu F, Paludetti G, Almadori G, De Virgilio A, Galli J, Micciche F, et al. Comparison of total laryngectomy with surgical (cricohyoidopexy) and nonsurgical organ-preservation modalities in advanced laryngeal squamous cell carcinomas: A multicenter retrospective analysis. Head Neck. 2013; 35(4): 554-561. DOI:10.1002/ hed.22994
De Virgilio A, Fusconi M, Gallo A, Greco A, Kim SH, Conte M, et al. The oncologic radicality of supracricoid partial laryngectomy with cricohyoidopexy in the treatment of advanced N0-N1 laryngeal squamous cell carcinoma. Laryngoscope 2012; 122(4): 826-833. DOI:10.1002/lary.23178
Patel KB, Nichols AC, Fung K, Yoo J, MacNeil SD. Treatment of early stage Supraglottic squamous cell carcinoma: meta-analysis comparing primary surgery versus primary radiotherapy. J Otolaryngol Head Neck Surg 2018; 47(1): 19. DOI:10.1186/s40463-018-0262-2
Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454(7203): 436-444. DOI:10.1038/nature07205
Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, et al. Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2011; 127(3): 701-721 e701-770. DOI:10.1016/j.jaci.2010.11.050
Wang F, Arun P, Friedman J, Chen Z, Van Waes C. Current and potential inflammation targeted therapies in head and neck cancer. Curr Opin Pharmacol. 2009; 9(4): 389-395. DOI:10.1016/j.coph.2009.06.005
Aloe L, Rocco ML, Balzamino BO, Micera A. Nerve growth factor: role in growth, differentiation and controlling cancer cell development. J Exp Clin Cancer Res 2016; 35(1): 116. DOI:10.1186/s13046-016-0395-y
Fiore M, Chaldakov GN, Aloe L. Nerve growth factor as a signaling molecule for nerve cells and also for the neuroendocrine-immune systems. Rev Neurosci 2009; 20(2): 133-145.
Aloe L, Manni L, Properzi F, De Santis S, Fiore M. Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by cisplatin: behavioral, structural and biochemical analysis. Auton Neurosci 2000; 86(1-2): 84-93. DOI:10.1016/S1566- 0702(00)00247-2
De Santis S, Pace A, Bove L, Cognetti F, Properzi F, Fiore M, et al. Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor. Clin Cancer Res. 2000; 6(1): 90-95.
Linkov F, Lisovich A, Yurkovetsky Z, Marrangoni A, Velikokhatnaya L, Nolen B, et al. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling. Cancer Epidemiol Biomarkers Prev. 2007; 16(1): 102-107. DOI:10.1158/1055-9965.EPI-06-0602
Druzgal CH, Chen Z, Yeh NT, Thomas GR, Ondrey FG, Duffey DC, et al. A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma. Head Neck. 2005; 27(9): 771-784. DOI:10.1002/hed.20246
Mojtahedi Z, Khademi B, Yehya A, Talebi A, Fattahi MJ, Ghaderi A. Serum levels of interleukins 4 and 10 in head and neck squamous cell carcinoma. J Laryngol Otol 2012; 126(2): 175-179. DOI:10.1017/S0022215111002349
Hathaway B, Landsittel DP, Gooding W, Whiteside TL, Grandis JR, Siegfried JM, et al. Multiplexed analysis of serum cytokines as biomarkers in squamous cell carcinoma of the head and neck patients. Laryngoscope 2005; 115(3): 522-527. DOI:10.1097/01. mlg.0000157850.16649.b8
Topping KP, Fletcher LM, Agada FO, Alhamarneh O, Stafford ND, Greenman J. Head and neck tumour immunology: basic concepts and new clinical implications. J Laryngol Otol 2009; 123(1): 9-18. DOI:10.1017/ S0022215108003368
Hoffmann TK, Sonkoly E, Homey B, Scheckenbach K, Gwosdz C, Bas M, et al. Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck. Head Neck. 2007; 29(5): 472-478. DOI:10.1002/hed.20533
Riedel F, Zaiss I, Herzog D, Gotte K, Naim R, Hormann K. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma. Anticancer Res. 2005; 25(4): 2761-2765.
Yang L, Huang Y, Zhou L, Dai Y, Hu G. High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: A systematic review and meta-analysis. Head Neck 2018. DOI:10.1002/hed.25583
Tham T, Bardash Y, Herman SW, Costantino PD. Neutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: A systematic review and meta-analysis. Head Neck. 2018; 40(11): 2546-2557. DOI:10.1002/hed.25324
Takenaka Y, Oya R, Kitamiura T, Ashida N, Shimizu K, Takemura K, et al. Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis. Head Neck 2018; 40(3): 647-655. DOI:10.1002/ hed.24986
Zhao QT, Yang Y, Xu S, Zhang XP, Wang HE, Zhang H, et al. Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients. Onco Targets Ther 2015; 8: 2731-2738. DOI:10.2147/ OTT.S90875
Mascarella MA, Mannard E, Silva SD, Zeitouni A. Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: A systematic review and meta-analysis. Head Neck 2018; 40(5): 1091-1100. DOI:10.1002/hed.25075
Du J, Liu J, Zhang X, Chen X, Yu R, Gu D, et al. Pre-treatment neutrophil-to-lymphocyte ratio predicts survival in patients with laryngeal cancer. Oncol Lett 2018; 15(2): 1664-1672. DOI:10.3892/ol.2017.7501
Alfaro C, Sanmamed MF, Rodriguez-Ruiz ME, Teijeira A, Onate C, Gonzalez A, et al. Interleukin-8 in cancer pathogenesis, treatment and follow-up. Cancer Treat Rev. 2017; 60: 24-31. DOI:10.1016/j.ctrv.2017.08.004
Maccalli C, Parmiani G, Ferrone S. Immunomodulating and immunoresistance properties of cancer-initiating cells: Implications for the clinical success of immunotherapy. Immunol Invest. 2017; 46(3): 221-238. DOI:10.1080/08 820139.2017.1280051
Kotyza J. Interleukin-8 (CXCL8) in tumor associated non-vascular extracellular fluids: its diagnostic and prognostic values. A review. Int J Biol Markers 2012; 27(3): 169-178. DOI:10.5301/JBM.2012.9261
Zhu YM, Webster SJ, Flower D, Woll PJ. Interleukin-8/ CXCL8 is a growth factor for human lung cancer cells. Br J Cancer 2004; 91(11): 1970-1976. DOI:10.1038/ sj.bjc.6602227
Li A, Varney ML, Singh RK. Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res 2001; 7(10): 3298-3304.
Atzpodien J, Kirchner H. Cancer, cytokines, and cytotoxic cells: interleukin-2 in the immunotherapy of human neoplasms. Klin Wochenschr 1990; 68(1): 1-11.
Hao W, Zhu Y, Zhou H. Prognostic value of interleukin-6 and interleukin-8 in laryngeal squamous cell cancer. Med Oncol. 2013; 30(1): 333. DOI:10.1007/s12032-012-0333-6
Wang Z, Gao ZM, Huang HB, Sun LS, Sun AQ, Li K. Association of IL-8 gene promoter-251 A/T and IL-18 gene promoter-137 G/C polymorphisms with head and neck cancer risk: a comprehensive meta-analysis. Cancer Manag Res. 2018; 10: 2589-2604. DOI:10.2147/CMAR. S165631
Guerra EN, Acevedo AC, Leite AF, Gozal D, Chardin H, De Luca Canto G. Diagnostic capability of salivary biomarkers in the assessment of head and neck cancer: A systematic review and meta-analysis. Oral Oncol 2015; 51(9): 805-818. DOI:10.1016/j.oraloncology.2015.06.010
Lee KD, Lee HS, Jeon CH. Body fluid biomarkers for early detection of head and neck squamous cell carcinomas. Anticancer Res 2011; 31(4): 1161-1167.
Kilic I, Guldiken S, Sipahi T, Palabiyik O, Akker M, Celik O, et al. Investigation of VEGF and IL-8 gene polymorphisms in patients with differentiated thyroid cancer. Clin Lab 2016; 62(12): 2319-2325. DOI:10.7754/ Clin.Lab.2016.160403
Gokhale AS, Haddad RI, Cavacini LA, Wirth L, Weeks L, Hallar M, et al. Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck. Oral Oncol. 2005; 41(1): 70-76. DOI:10.1016/j.oraloncology.2004.06.005
Bleotu C, Chifiriuc MC, Grigore R, Grancea C, Popescu CR, Anton G, et al. Investigation of Th1/Th2 cytokine profiles in patients with laryngo-pharyngeal, HPV-positive cancers. Eur Arch Otorhinolaryngol 2013; 270(2): 711- 718. DOI:10.1007/s00405-012-2067-7
Li KC, Huang YH, Ho CY, Chu CY, Cha ST, Tsai HH, et al. The role of IL-8 in the SDF-1alpha/CXCR4-induced angiogenesis of laryngeal and hypopharyngeal squamous cell carcinoma. Oral Oncol 2012; 48(6): 507-515. DOI:10.1016/j.oraloncology.2012.01.006
Swenson WG, Wuertz BR, Ondrey FG. Tobacco carcinogen mediated up-regulation of AP-1 dependent pro-angiogenic cytokines in head and neck carcinogenesis. Mol Carcinog 2011; 50(9): 668-679. DOI:10.1002/ mc.20775
Melinceanu L, Sarafoleanu C, Lerescu L, Tucureanu C, Caras I, Salageanu A. Impact of smoking on the immunological profile of patients with laryngeal carcinoma. J Med Life 2009; 2(2): 211-218.
Eyigor M, Eyigor H, Osma U, Yilmaz MD, Erin N, Selcuk OT, et al. Analysis of serum cytokine levels in larynx squamous cell carcinoma and dysplasia patients. Iran J Immunol 2014; 11(4): 259-268. DOI:IJIv11i4A4
Starska K, Forma E, Brys M, Glowacka E, Lewy-Trenda I, Lukomski M, et al. The expression of TLR pathway molecules in peripheral blood mononuclear cells and their relationship with tumor invasion and cytokine secretion in laryngeal carcinoma. Adv Med Sci 2012; 57(1): 124-135. DOI:10.2478/v10039-011-0058-3
Szczepanski M, Stelmachowska M, Stryczynski L, Golusinski W, Samara H, Mozer-Lisewska I, et al. Assessment of expression of toll-like receptors 2, 3 and 4 in laryngeal carcinoma. Eur Arch Otorhinolaryngol 2007; 264(5): 525-530. DOI:10.1007/s00405-006-0215-7
Ralli M, de Vincentiis M, Greco A. Large parapharyngeal mass: a challenging differential diagnosis. Lancet Oncol 2018 Mar;19(3):e181. DOI:10.1016/S1470- 2045(17)30579-X.
Altissimi G, Ralli M, Sementilli G, Fiorentino F, et al. Adult-Type Rhabdomyoma of the Larynx: Clinicopathologic Study of an Uncommon Tumor in a Rare Location. Case Rep Otolaryngol 2017;2017:7186768. DOI:10.1155/2017/7186768
Ralli M, de Vincentiis M, Greco A. First, Rule Out Cancer: Giant Lipoma. Am J Med 2018 Feb;131(2):146-147. DOI:10.1016/j.amjmed.2017.09.013.
Ralli M, Altissimi G, Turchetta R, Rigante M. Metastatic Renal Cell Carcinoma Presenting as a Paranasal Sinus Mass: The Importance of Differential Diagnosis. Case Rep Otolaryngol 2017;2017:9242374. DOI:10.1155/2017/9242374.
Email this article (Login required) 
